Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers: Divergence Between Fundamentals And Valuation
02:03am, Wednesday, 16'th Aug 2023
Q2 Revenue beat analyst estimates by $3M. Gross Margin improved despite price cuts. Management raised guidance by $20M, which also beat estimates by $19M.
Could Hims & Hers Health Stock Help You Become a Millionaire?
06:48am, Sunday, 13'th Aug 2023
Hims & Hers Health keeps turning in stellar operating results. But shares have slid 30% over the past few months.
Is Hims & Hers Health Stock a Must Buy Under $10?
11:00am, Wednesday, 09'th Aug 2023
This potential multibagger stock is being underappreciated by the market. Here's why Hims & Hers stock is a buy right now.
Hims & Hers Health, Inc. (HIMS) Q2 2023 Earnings Call Transcript
10:07pm, Monday, 07'th Aug 2023
Hims & Hers Health, Inc. (NYSE:HIMS ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Alice Lopatto - Vice President, Investor Relations Andrew Dudum - Co-Founder & Chi
Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates
08:24pm, Monday, 07'th Aug 2023
Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.10 per share a year ago.
Hims & Hers stock jumps 13% after narrower loss in Q2
04:55pm, Monday, 07'th Aug 2023
Hims & Hers Health Inc. HIMS, -3.07% shares rallied nearly 13% in the aftermarket Monday after the telehealth company reported a narrower-than-expected loss for its second quarter and revenue that was
Hims & Hers to Announce Second Quarter 2023 Financial Results on August 7, 2023
09:00am, Monday, 24'th Jul 2023
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2023 financial re
Hims & Hers: Market Blows Off Short Report
03:03pm, Friday, 14'th Jul 2023
Spruce Capital Management issued a short report on Hims & Hers Health, Inc., but the call actually only forecast downside risk to $5. The health and wellness company continues to grow at a fast clip w
The More This Potential Multibagger Stock Drops, The More I Buy
06:18am, Thursday, 13'th Jul 2023
Hims & Hers Health stock has fallen since its last earnings report. Wall Street could be misinterpreting the company's high marketing spend.
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
10:05am, Wednesday, 12'th Jul 2023
Hims & Hers has a booming telemedicine business that could grow by 57% this year. Viking Therapeutics has a promising pipeline that features a couple of potential blockbuster drugs.
How to Find the Best Cheap Stocks Under $10 to Buy in July
04:18pm, Tuesday, 11'th Jul 2023
Today we dive into a pocket of the stock market that many investors like to own as part of diversified portfolios: cheap stocks trading for $10 a share or less. Along with the cheap price tag, the sto
7 Small-Cap Stocks That Have Insiders Running for the Exit
05:39pm, Monday, 26'th Jun 2023
Given the riskier and more speculative nature of small-cap stocks, if you own a stock in this category, it's important to keep an eye out for signs that said name has become one of the small-cap stock
My 3 Favorite Stocks Right Now
05:30am, Friday, 16'th Jun 2023
Amazon is still attractively valued for its growth potential. Hims & Hers isn't getting the respect it deserves.
Hims & Hers: Sell-Off Opportunity
04:06am, Monday, 12'th Jun 2023
Hims & Hers plunged after Q2 adjusted EBITDA guidance disappointed Wall Street. The online health and wellness company has massive growth opportunities ahead and continues investing aggressively in ma
Hims & Hers: More Transparency Could Help The Stock
03:45am, Friday, 09'th Jun 2023
Hims & Hers stock has struggled despite strong Q1 earnings and raised full-year guidance, with shares down over 20% since the report. HIMS' subscriber count grew 87% YoY to 1.209 million, and it is in
